Target intelligence / Profile preview

Staphylococcus aureus surface protein

Molecular classification
Other, Adhesin, Virulence factor, Bacterial surface protein
01

Overview

The “Staphylococcus aureus surface antigen” is not a single, defined molecular target, but refers generically to the large and diverse family of **surface-expressed proteins** found on Staphylococcus aureus. These proteins, often called **cell wall-anchored (CWA) surface proteins**, are covalently attached to the bacterial cell wall via the action of the enzyme sortase A[1][6]. Prominent among these are the **MSCRAMM family** (Microbial Surface Components Recognizing Adhesive Matrix Molecules), which includes proteins such as protein A (SpA), clumping factor A (ClfA), and the iron-regulated surface determinant proteins (IsdA/IsdB)[1][6]. Each protein mediates specific functions: adhesion to host tissues, evasion of the host immune system, biofilm formation, iron acquisition, and direct invasion of host cells[1][5][6]. These surface proteins are crucial for S. aureus virulence and pathogenesis in a variety of infections. They are recognized as important therapeutic and vaccine targets, with some being evaluated as antigens in multicomponent vaccines[1][5]. However, since “Staphylococcus aureus surface antigen” does not uniquely specify any single protein, the term is overly broad and non-specific, and thus is not optimal for drug or vaccine development targeting, where specific proteins (e.g., SpA, ClfA) are more appropriate. Caveats and notes: - **is_incorrect** is true because “Staphylococcus aureus surface antigen” is a generic, non-specific term, not a unique molecular entity. Proper targets should specify a particular surface protein, such as “Staphylococcus aureus protein A” or “Staphylococcus aureus clumping factor A”[1][6]. - The canonical name should be updated to point to a specific well-characterized surface protein for precise research, therapeutic targeting, or data structuring. - For antibody, drug, or vaccine targeting, it is critical to specify which S. aureus surface protein is being considered[1][5][6].

Other names
Cell wall-anchored surface proteinCWA proteinStaphylococcal surface-associated antigenMSCRAMM (for family)specific examples include "Protein A" (SpA)"Clumping factor A" (ClfA)"Fibronectin binding protein" (FnBP)"Iron-regulated surface determinant" (IsdA/IsdB)"Serine-rich adhesin for platelets" (SraP/SasA)etc.
02

Mechanism of action

Blockade of adhesion to host tissues Neutralization of immune evasion mechanisms Inhibition of biofilm formation Disruption of iron uptake

03

Biological functions

Host adhesionBiofilm formationImmune evasionIron acquisitionInvasion of host cellsModulation of inflammation
04

Disease associations

InfectionInflammation
05

Safety considerations

Immune cross-reactivity (potential autoimmune responses)Antigenic variation limiting efficacyRedundancy of virulence mechanisms
06

Interacting drugs

Antibodies used in vaccine development (e.g., anti-Protein A antibodies)[4][5]

1 more in the full profile.

07

Biomarkers

Protein A (SpA) expression as a marker for S. aureus presenceClumping factor A (ClfA) as a vaccine candidate antigenIsdA/IsdB as diagnostic/vaccine targets

Beyond the preview

Go deeper on Staphylococcus aureus surface protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus surface protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call